Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1068 of 1,261
  1. US 7329638

    Drug delivery compositions

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted
  2. US 7329511

    Nucleic acid encoding GAD65

    The Regents of the University of California · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted
  3. US 7329752

    Carbamate compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted
  4. US 7329642

    β-2-glycoprotein is an inhibitor of angiogenesis

    The Board of Regents of the University of Texas System · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted
  5. US 7326570

    Induction of tubular morphogenesis using pleiotrophin

    The Regents of the University of California · Granted Feb 5, 2008 · Expires Jan 31, 2028

    granted
  6. US 7326734

    Treatment of bladder and urinary tract cancers

    The Regents of the University of California · Granted Feb 5, 2008 · Expires Jan 31, 2028

    granted
  7. US 7326713

    Substituted tricyclic compound as protein kinase inhibitors

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Feb 5, 2008 · Expires Jan 31, 2028

    granted
  8. US 7326712

    Substituted tricyclic compounds as protein kinase inhibitors

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Feb 5, 2008 · Expires Jan 31, 2028

    granted
  9. US 7326697

    Methods for increasing the therapeutic response to electroconvulsive therapy

    Corcept Therapeutics Incorporated · Granted Feb 5, 2008 · Expires Jan 31, 2028

    granted
  10. US 7326790

    Diphenylisoxazole compounds and hydro isomers thereof

    Rigel Pharmaceuticals, Inc. · Granted Feb 5, 2008 · Expires Jan 31, 2028

    granted
  11. US 7326542

    Compositions and methods for regulating bacterial pathogenesis

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Feb 5, 2008 · Expires Jan 31, 2028

    granted
  12. US 7326695

    Anti-bacterial agents based upon oxoanion binding

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Feb 5, 2008 · Expires Jan 31, 2028

    granted
  13. US 7326691

    Compositions comprising amphotericin B, methods, and systems

    Nektar Therapeutics · Granted Feb 5, 2008 · Expires Jan 31, 2028

    granted
  14. EP 1882730

    Systemreinigerkonzentrat

    AIR LIQUIDE SANTE INT [FR] · Granted Jan 30, 2008 · Expires Jan 25, 2028

    granted
  15. US 7323174

    Modulation of immune response and methods based thereon

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jan 29, 2008 · Expires Jan 24, 2028

    granted
  16. US 7323165

    Production of pancreatic islet cells and delivery of insulin

    The Regents of the University of California · Granted Jan 29, 2008 · Expires Jan 24, 2028

    granted
  17. US 7323541

    Polypeptide DNA thereof and use of the same

    Takeda Pharmaceutical Company Limited · Granted Jan 29, 2008 · Expires Jan 24, 2028

    granted
  18. US 7323616

    Genetically altered mice deficient in functional caspase-9

    Vertex Pharmaceuticals Incorporated · Granted Jan 29, 2008 · Expires Jan 24, 2028

    granted
  19. US 7323459

    Crystal forms, methods for their preparation and method for preparation of olanzapine

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jan 29, 2008 · Expires Jan 24, 2028

    granted
  20. US 7323340

    Compositions and methods for regulating bacterial pathogenesis

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jan 29, 2008 · Expires Jan 24, 2028

    granted
  21. US 7323334

    Screening and therapeutic methods relating to neurogenesis

    The Regents of the University of California · Granted Jan 29, 2008 · Expires Jan 24, 2028

    granted
  22. US 7323297

    Stabilized polynucleotide complexes and methods

    The Regents of the University of California · Granted Jan 29, 2008 · Expires Jan 24, 2028

    granted
  23. US 7323166

    Lactic acid bacteria cultures that inhibit food-borne pathogens

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jan 29, 2008 · Expires Jan 24, 2028

    granted
  24. US 7323171

    Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 29, 2008 · Expires Jan 24, 2028

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.